{"id":"https://openalex.org/W2995319359","doi":"https://doi.org/10.1210/clinem/dgz258","title":"Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption","display_name":"Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption","publication_year":2019,"publication_date":"2019-12-14","ids":{"openalex":"https://openalex.org/W2995319359","doi":"https://doi.org/10.1210/clinem/dgz258","mag":"2995319359","pmid":"https://pubmed.ncbi.nlm.nih.gov/31837264","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7067537"},"language":"en","primary_location":{"id":"doi:10.1210/clinem/dgz258","doi":"https://doi.org/10.1210/clinem/dgz258","is_oa":true,"landing_page_url":"https://doi.org/10.1210/clinem/dgz258","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1210/clinem/dgz258","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011062127","display_name":"David R. Powell","orcid":"https://orcid.org/0000-0001-8072-388X","observed_orcids":["https://orcid.org/0000-0001-8072-388X","https://orcid.org/0000-0003-0656-0124"]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David R Powell","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc, The Woodlands, Texas"],"raw_orcid":"https://orcid.org/0000-0003-0656-0124","affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc, The Woodlands, Texas","institution_ids":["https://openalex.org/I4210094785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041036914","display_name":"Brian Zambrowicz","orcid":"https://orcid.org/0000-0001-8831-0406","observed_orcids":["https://orcid.org/0000-0001-8831-0406"]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Zambrowicz","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc, The Woodlands, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc, The Woodlands, Texas","institution_ids":["https://openalex.org/I4210094785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084625858","display_name":"Linda Morrow","orcid":"https://orcid.org/0000-0003-3252-4477","observed_orcids":["https://orcid.org/0000-0003-3252-4477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda Morrow","raw_affiliation_strings":["ProSciento, Inc, Chula Vista, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProSciento, Inc, Chula Vista, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035102402","display_name":"Carine Beysen","orcid":"https://orcid.org/0000-0002-2259-0932","observed_orcids":["https://orcid.org/0000-0002-2259-0932"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carine Beysen","raw_affiliation_strings":["ProSciento, Inc, Chula Vista, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProSciento, Inc, Chula Vista, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044166679","display_name":"Marcus Hompesch","orcid":"https://orcid.org/0000-0001-5867-2131","observed_orcids":["https://orcid.org/0000-0001-5867-2131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcus Hompesch","raw_affiliation_strings":["ProSciento, Inc, Chula Vista, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ProSciento, Inc, Chula Vista, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041108969","display_name":"Scott Turner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120936","display_name":"Pliant (United States)","ror":"https://ror.org/02myr1w18","country_code":"US","type":"company","lineage":["https://openalex.org/I4210120936"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Turner","raw_affiliation_strings":["Pliant Therapeutics, South San Francisco, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pliant Therapeutics, South San Francisco, California","institution_ids":["https://openalex.org/I4210120936"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047114493","display_name":"Marc K. Hellerstein","orcid":"https://orcid.org/0000-0002-2327-0834","observed_orcids":["https://orcid.org/0000-0002-2327-0834"]},"institutions":[{"id":"https://openalex.org/I95457486","display_name":"University of California, Berkeley","ror":"https://ror.org/01an7q238","country_code":"US","type":"education","lineage":["https://openalex.org/I95457486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Hellerstein","raw_affiliation_strings":["University of California, Berkeley, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Berkeley, California","institution_ids":["https://openalex.org/I95457486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050005771","display_name":"Phillip Lee Banks","orcid":"https://orcid.org/0009-0001-7333-8374","observed_orcids":["https://orcid.org/0009-0001-7333-8374"]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip Banks","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc, The Woodlands, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc, The Woodlands, Texas","institution_ids":["https://openalex.org/I4210094785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053324412","display_name":"Paul Strumph","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Strumph","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc, The Woodlands, Texas","Metavant Sciences, Ltd., Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc, The Woodlands, Texas","institution_ids":["https://openalex.org/I4210094785"]},{"raw_affiliation_string":"Metavant Sciences, Ltd., Durham, North Carolina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075068326","display_name":"Pablo Lapuerta","orcid":"https://orcid.org/0000-0003-0704-0251","observed_orcids":["https://orcid.org/0000-0003-0704-0251"]},"institutions":[{"id":"https://openalex.org/I4210094785","display_name":"Lexicon Pharmaceuticals (United States)","ror":"https://ror.org/00v64s089","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094785"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pablo Lapuerta","raw_affiliation_strings":["Lexicon Pharmaceuticals, Inc, The Woodlands, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lexicon Pharmaceuticals, Inc, The Woodlands, Texas","institution_ids":["https://openalex.org/I4210094785"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5011062127"],"corresponding_institution_ids":["https://openalex.org/I4210094785"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":{"value":3750,"currency":"USD","value_usd":3750},"fwci":3.6895,"has_fulltext":false,"cited_by_count":60,"citation_normalized_percentile":{"value":0.96598527,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"105","issue":"4","first_page":"e1235","last_page":"e1249"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotagliflozin","display_name":"sotagliflozin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sglt1-inhibition","display_name":"SGLT1 inhibition","score":0.8420000076293945},{"id":"https://openalex.org/keywords/sglt2-inhibition","display_name":"SGLT2 inhibition","score":0.9290000200271606},{"id":"https://openalex.org/keywords/intestinal-glucose-uptake","display_name":"intestinal glucose absorption","score":0.9750000238418579},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.9800000190734863},{"id":"https://openalex.org/keywords/postprandial-insulin","display_name":"postprandial insulin","score":0.9779999852180481},{"id":"https://openalex.org/keywords/mixed-meal","display_name":"mixed meal","score":0.6949999928474426},{"id":"https://openalex.org/keywords/type-2-diabetes-treatment","display_name":"type 2 diabetes treatment","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.9282814264297485},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.8427771329879761},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6903479099273682},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6413058638572693},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6296367645263672},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5727010369300842},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5603541731834412},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49721458554267883},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4832073450088501},{"id":"https://openalex.org/C2778345441","wikidata":"https://www.wikidata.org/wiki/Q6460735","display_name":"Meal","level":2,"score":0.4667905271053314},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3148338198661804},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2311493456363678},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019518","descriptor_name":"Postprandial Period","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1210/clinem/dgz258","doi":"https://doi.org/10.1210/clinem/dgz258","is_oa":true,"landing_page_url":"https://doi.org/10.1210/clinem/dgz258","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6028254","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7067537","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7067537","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7067537","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Endocrinol Metab","raw_type":"Text"},{"id":"pmid:31837264","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31837264","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1210/clinem/dgz258","doi":"https://doi.org/10.1210/clinem/dgz258","is_oa":true,"landing_page_url":"https://doi.org/10.1210/clinem/dgz258","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1946307024","https://openalex.org/W1979283687","https://openalex.org/W1997018189","https://openalex.org/W2004363547","https://openalex.org/W2013892321","https://openalex.org/W2052526874","https://openalex.org/W2052764225","https://openalex.org/W2058969403","https://openalex.org/W2072812733","https://openalex.org/W2075627118","https://openalex.org/W2112043952","https://openalex.org/W2119843247","https://openalex.org/W2131135469","https://openalex.org/W2133469996","https://openalex.org/W2146264128","https://openalex.org/W2151470569","https://openalex.org/W2157405334","https://openalex.org/W2157538794","https://openalex.org/W2166613497","https://openalex.org/W2168817129","https://openalex.org/W2171183320","https://openalex.org/W2175616918","https://openalex.org/W2256112701","https://openalex.org/W2424539745","https://openalex.org/W2563224755","https://openalex.org/W2608481654","https://openalex.org/W2626446274","https://openalex.org/W2755899227","https://openalex.org/W2780617792","https://openalex.org/W2794825506","https://openalex.org/W2808915250","https://openalex.org/W2809153459","https://openalex.org/W2809312083","https://openalex.org/W2809590939","https://openalex.org/W2884380775","https://openalex.org/W2891930016","https://openalex.org/W2894624538","https://openalex.org/W2894694027","https://openalex.org/W2896925990","https://openalex.org/W2897457722","https://openalex.org/W2918957897","https://openalex.org/W2955843024","https://openalex.org/W2981245266"],"related_works":["https://openalex.org/W2944215003","https://openalex.org/W2131135469","https://openalex.org/W2188672568","https://openalex.org/W4415018400","https://openalex.org/W2920884286","https://openalex.org/W4381377228","https://openalex.org/W2115247225","https://openalex.org/W2324962627","https://openalex.org/W2153635840","https://openalex.org/W4285044451"],"abstract_inverted_index":{"CONTEXT:":[0],"The":[1],"effect":[2],"of":[3,28,30,73,86,98,250],"sotagliflozin":[4,47,88,210],"(a":[5],"dual":[6,36],"sodium-glucose":[7],"cotransporter":[8],"[SGLT]":[9],"2":[10,71,127],"and":[11,103,118,137,171,176,191,215,222,230,241],"SGLT1":[12,252],"inhibitor)":[13],"on":[14,96],"intestinal":[15,232,251],"glucose":[16,32,37,114,122,133,141,154,169,233],"absorption":[17,234],"has":[18],"not":[19],"been":[20],"investigated":[21],"in":[22,238],"humans.":[23],"OBJECTIVE:":[24],"To":[25],"measure":[26],"rate":[27],"appearance":[29],"oral":[31,84],"(RaO)":[33],"using":[34],"a":[35,59,148],"tracer":[38],"method":[39],"following":[40],"standardized":[41],"mixed":[42],"meals":[43],"taken":[44],"after":[45,193,235,258],"single":[46,83],"or":[48,94],"canagliflozin":[49,91,177,223],"doses.":[50],"SETTING:":[51],"Clinical":[52],"research":[53],"organization.":[54],"DESIGN":[55],"AND":[56],"PARTICIPANTS:":[57],"In":[58],"double-blind,":[60],"3-period":[61],"crossover":[62],"study":[63],"(NCT01916863),":[64],"24":[65],"healthy":[66],"participants":[67,79,146],"were":[68,80],"randomized":[69],"to":[70,150,246],"cohorts":[72],"12":[74],"participants.":[75],"Within":[76],"each":[77,97],"cohort,":[78],"randomly":[81],"assigned":[82],"doses":[85],"either":[87],"400":[89],"mg,":[90,93],"300":[92],"placebo":[95,221],"test":[99,106],"days":[100],"1,":[101],"8,":[102],"15.":[104],"On":[105],"days,":[107],"Cohort":[108,126],"1":[109],"had":[110,128],"breakfast":[111,129,194],"containing":[112,120,130,139],"[6,6-2H2]":[113,140,162],"0.25":[115,134],"hours":[116,124,135,143,158,187,218,257],"postdose":[117,136,198,208],"lunch":[119,138,199],"[1-2H1]":[121],"5.25":[123],"postdose;":[125],"no":[131],"labeled":[132],"4.25":[142],"postdose.":[144],"All":[145],"received":[147],"10-":[149],"15-hour":[151],"continuous":[152],"[U-13C6]":[153],"infusion":[155],"starting":[156],"5":[157],"before":[159],"their":[160],"first":[161],"glucose-containing":[163],"meal.":[164],"MAIN":[165],"OUTCOME:":[166],"RaO,":[167,189],"postprandial":[168,172],"(PPG),":[170],"insulin.":[173],"RESULTS:":[174],"Sotagliflozin":[175,228],"decreased":[178],"area":[179],"under":[180],"the":[181,196,206],"curve":[182],"(AUC)0-1":[183],"hour":[184,214],"and/or":[185,195],"AUC0-2":[186],"for":[188,255],"PPG,":[190],"insulin":[192,242],"4.25-hour":[197],"(P":[200,224],"<":[201,225],".05":[202],"versus":[203,219],"placebo).":[204],"After":[205],"5.25-hour":[207],"lunch,":[209],"lowered":[211],"RaO":[212],"AUC0-1":[213],"PPG":[216,240],"AUC0-5":[217],"both":[220],".05).":[226],"CONCLUSIONS:":[227],"delayed":[229],"blunted":[231],"meals,":[236],"resulting":[237],"lower":[239],"levels,":[243],"likely":[244],"due":[245],"prolonged":[247],"local":[248],"inhibition":[249],"that":[253],"persisted":[254],"\u22655":[256],"dosing.":[259]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-12-26T00:00:00"}